Hormone linked to blood pressure may cause osteoarthritis

A hormone associated with blood pressure, called vasopressin, may contribute to the development of osteoarthritis, according to a study published in Science on October 1, 2026, by researchers from Chonnam National University in South Korea. The findings suggest that osteoarthritis could have a hormonal component, linking high blood pressure to cartilage damage.

Osteoarthritis viewed through a new lens

Traditionally, osteoarthritis has been understood as a result of wear and tear, obesity, and aging. This study, however, proposes a different perspective, suggesting that the condition may originate in the bloodstream, particularly affecting joints that are already damaged.

Vasopressin and its role in hypertension

People with high blood pressure have higher levels of vasopressin, a hormone that constricts blood vessels and helps the body retain water. This hormone only exerts its effects when it interacts with a specific receptor called AVPR1A found on cell walls. Healthy cartilage contains very little of this receptor, making it largely unaffected by vasopressin.

Aging and injury change the equation

As people age or experience joint injuries, the cartilage cells begin to produce more of the AVPR1A receptor. This allows vasopressin to bind to the cells, initiating a chain of chemical reactions that break down the cartilage. The study suggests that while injury creates the conditions for this process, high blood pressure acts as the triggering signal.

Blocking the receptor reduces damage in mice

In experiments on mice, blocking the AVPR1A receptor reduced the damage caused by vasopressin. This finding offers a potential new approach to treating osteoarthritis by targeting the hormonal pathway involved in its development.